Wu Jing-Fang, Liu Ming-Ming, Huang Shao-Xu, Wang Yang
Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China.
State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China.
Bioorg Med Chem Lett. 2015 Aug 15;25(16):3251-5. doi: 10.1016/j.bmcl.2015.05.082. Epub 2015 May 31.
Two series of novel 1,5-naphthyridine and 1,6-naphthyridine derivatives were designed and synthesized based on the c-Met kinase inhibitor MK-2461 under the guidance of scaffold hopping strategy. All were tested on c-Met kinase and in vitro anti-tumor activities against Hela and A549 cell lines. The results indicated that 1,6-naphthyridine was a more promising c-Met inhibitory structure core compared with 1,5-naphthyridine. Among them, 26b and 26c showed the best enzymic and cytotoxic activities. The western blot experiments implied that the cytotoxic activity of 26c might be partially through suppressing the phosphorylation of c-Met kinase.
基于骨架跃迁策略,以c-Met激酶抑制剂MK-2461为导向,设计并合成了两个系列的新型1,5-萘啶和1,6-萘啶衍生物。所有化合物均针对c-Met激酶进行了测试,并对Hela和A549细胞系进行了体外抗肿瘤活性测试。结果表明,与1,5-萘啶相比,1,6-萘啶是更有前景的c-Met抑制结构核心。其中,26b和26c表现出最佳的酶活性和细胞毒性活性。蛋白质免疫印迹实验表明,26c的细胞毒性活性可能部分是通过抑制c-Met激酶的磷酸化来实现的。